Profile of Robert Wilkinson
Robert Wilkinson is Director of Oncology Research at MedImmune Ltd, the biologics arm of AstraZeneca. Based in Cambridge, his group is charged with the generation and delivery of new candidate biotherapeutics. His research focuses on immunotherapies, as well as tumour targeted therapies using the latest antibody and protein based strategies. Robert has over fifteen years of experience in the biotech and pharmaceutical industries, in both small and large molecule cancer drug discovery, and translational science. Previously he has held senior leadership roles with AstraZeneca and Cancer Research Technology.